Filters

Drugs & aging

Showing results (1491-1500 of 2,791) with videos related to

Pageof 280
Sort By:
Drugs & Aging|April 1, 1996
Oral naftidrofuryl. A review of its pharmacology and therapeutic use in the management of peripheral occlusive arterial diseaseL B Barradell, R N Brogden
Drugs & Aging|November 1, 1996
Nonsteroidal anti-inflammatory drugs and acute renal failure in the elderly. A risk-benefit assessmentW Ailabouni, G Eknoyan
Drugs & Aging|November 1, 1996
Optimal treatment of urinary tract infections in elderly patientsC A Wood, E Abrutyn
Drugs & Aging|November 1, 1996
Latanoprost. A review of its pharmacological properties, clinical efficacy and tolerability in the management of primary open-angle glaucoma and ocular hypertensionS S Patel, C M Spencer
Drugs & Aging|February 1, 1996
Anti-amyloid drugs: potential in the treatment of diseases associated with agingR Kisilevsky
Drugs & Aging|September 1, 1996
Optimal management of anxiety in older patientsK J Weiss
Drugs & Aging|October 1, 1996
Formestane. A review of its pharmacological properties and clinical efficacy in the treatment of postmenopausal breast cancerL R Wiseman, K L Goa
Drugs & Aging|May 1, 1996
Optimal treatment of angina in older patientsR N Doughty, N Sharpe
Drugs & Aging|December 1, 1996
Selective inhibitors of cyclooxygenase-2. Potential in elderly patientsN M Davies, J L Wallace
Drugs & Aging|June 1, 1996
Tuberculosis in the elderly. Epidemiology and optimal managementP D Davies
Pageof 280

Showing results (1491-1500 of 2,791) with videos related to

Sort By:
Pageof 280
Drugs & Aging|April 1, 1996
Oral naftidrofuryl. A review of its pharmacology and therapeutic use in the management of peripheral occlusive arterial diseaseL B Barradell, R N Brogden
Drugs & Aging|November 1, 1996
Nonsteroidal anti-inflammatory drugs and acute renal failure in the elderly. A risk-benefit assessmentW Ailabouni, G Eknoyan
Drugs & Aging|November 1, 1996
Optimal treatment of urinary tract infections in elderly patientsC A Wood, E Abrutyn
Drugs & Aging|November 1, 1996
Latanoprost. A review of its pharmacological properties, clinical efficacy and tolerability in the management of primary open-angle glaucoma and ocular hypertensionS S Patel, C M Spencer
Drugs & Aging|February 1, 1996
Anti-amyloid drugs: potential in the treatment of diseases associated with agingR Kisilevsky
Drugs & Aging|September 1, 1996
Optimal management of anxiety in older patientsK J Weiss
Drugs & Aging|October 1, 1996
Formestane. A review of its pharmacological properties and clinical efficacy in the treatment of postmenopausal breast cancerL R Wiseman, K L Goa
Drugs & Aging|May 1, 1996
Optimal treatment of angina in older patientsR N Doughty, N Sharpe
Drugs & Aging|December 1, 1996
Selective inhibitors of cyclooxygenase-2. Potential in elderly patientsN M Davies, J L Wallace
Drugs & Aging|June 1, 1996
Tuberculosis in the elderly. Epidemiology and optimal managementP D Davies
Pageof 280
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us